Investments & Funding

Under the deal, AbbVie gains exclusive rights to develop, manufacture, and commercialize ISB 2001 across major markets including North America, Europe, Japan, and Greater China.

Merck aims to enhance its respiratory portfolio with the acquisition of Ohtuvayre (ensifentrine), a newly approved inhaled treatment for chronic obstructive pulmonary disease (COPD), also known as “smoker’s lung.”

The funds will also support the expansion of its world-class team, spanning research and development, product design, and operations.

The new center, spanning nearly 30,000 square feet, is the largest cleft care facility on the African continent.

This pioneering facility, equipped with the cutting-edge Da Vinci Robotic Surgical System, is set to revolutionize urological care and enhance patient outcomes.

Charité and Siemens Healthineers will launch joint research projects to create faster and more precise diagnostic and treatment methods using AI.

The partnership resulted in a unique educational program that incorporates insights from the Moscow Experiment, a groundbreaking project in AI for medical imaging.

This new hospital, with 120 beds, offers a comprehensive range of services, including outpatient care, emergency treatment, and specialised medical attention.

This dedicated facility is designed to provide fast, general practitioner (GP)-led care for patients with urgent but non-life-threatening medical issues.

This decision is aimed at ensuring the swift and efficient delivery of Novo Nordisk’s promised investment of over 2 billion euros (US$2.34 billion) in a manufacturing facility located south of Rome.